These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31159823)

  • 1. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
    Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
    Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
    Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
    Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape
    Hu JQ; Lei BW; Wen D; Ma B; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Li DS; Ji QH; Liao T
    J Cancer; 2020; 11(14):4250-4260. PubMed ID: 32368308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.
    Angell TE; Lechner MG; Jang JK; LoPresti JS; Epstein AL
    Clin Cancer Res; 2014 Dec; 20(23):6034-44. PubMed ID: 25294906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
    Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteomics and Organoid Culture Reveal the Underlying Pathogenesis of Hashimoto's Thyroiditis.
    Xiao H; Liang J; Liu S; Zhang Q; Xie F; Kong X; Guo S; Wang R; Fu R; Ye Z; Li Y; Zhang S; Zhang L; Kaudimba KK; Wang R; Kong X; Zhao B; Zheng X; Liu T
    Front Immunol; 2021; 12():784975. PubMed ID: 34925365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis.
    Zivancevic-Simonovic S; Mihaljevic O; Majstorovic I; Popovic S; Markovic S; Milosevic-Djordjevic O; Jovanovic Z; Mijatovic-Teodorovic L; Mihajlovic D; Colic M
    Cancer Immunol Immunother; 2015 Aug; 64(8):1011-9. PubMed ID: 25971541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
    Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
    Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
    Hirokawa M; Nishihara E; Takada N; Higuchi M; Kotakemori M; Hayashi T; Miyauchi A
    Endocr J; 2018 Feb; 65(2):175-180. PubMed ID: 29093307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?
    Ehlers M; Schott M
    Trends Endocrinol Metab; 2014 Dec; 25(12):656-64. PubMed ID: 25306886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
    Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study.
    Yang Y; Liu J; Shi X; Wang M
    Cancer Control; 2023; 30():10732748231199647. PubMed ID: 37643366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
    Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
    Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto's Thyroiditis.
    Cui L; Zhang C; Ding H; Feng D; Huang H; Lu Z; Liu B
    Front Immunol; 2022; 13():821601. PubMed ID: 35720279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
    Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
    Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
    Liu Y; Yun X; Gao M; Yu Y; Li X
    Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary thyroid cancer with Hashimoto's thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression.
    Kim SJ; Lee SE; Kim YI; Nam-Goong IS; Jung HW; Kim ES
    Clin Exp Med; 2023 Jul; 23(3):833-840. PubMed ID: 35871446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis.
    Molnár C; Molnár S; Bedekovics J; Mokánszki A; Győry F; Nagy E; Méhes G
    Pathol Oncol Res; 2019 Jul; 25(3):1191-1197. PubMed ID: 30666518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.